Discover 1,055 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,055
Active & ResponsiveNew
CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients
for
Kidney Transplant; Complications, CMV
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18 - 70
Code: NCT07096453
Phase1, Phase2, Recruiting
Active & Responsive
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: Saint Paul MN, Iowa City IA, Detroit MI, Louisville KY,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05719558
Phase1, Recruiting
Active & Responsive
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: Saint Paul MN, St Louis MO, Toronto, Atlanta GA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Recruiting
Active & Responsive
Novel Post-Surgical Incision Management to Prevent Ostomy Complications
for
Ostomy, Enterocutaneous Fistula
Location: Saint Paul MN
Sponsor: HealthPartners Institute
Sex: All
Age: 18+
Code: NCT06524401
Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Saint Paul MN, Saint Louis Park MN, Iowa City IA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Saint Paul MN, Madison WI, Saint Louis MO, Cleveland OH,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase1, Recruiting
Active & Responsive
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
for
Recurrent Endometrial Carcinoma,
Location: Saint Paul MN, Minneapolis MN, Saint Louis Park MN,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT05554328
Phase2, Recruiting
Active & Responsive
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Saint Paul MN, Maplewood MN, Woodbury MN,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Active & Responsive
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Saint Paul MN, Maplewood MN, Woodbury MN,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer